Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > ILMN Illumina > Company Executives
ILMN Illumina
216.910
-2.080-0.95%
Pre Mkt Price
216.9100.0000.00%
NamePositionSalaryService DateEducationAgeGenderUpdated
Mr. Francis A. DeSouzaPresident, Chief Executive Officer and Director14.33M----51male04/14/2022
Mr. Robert RagusaChief Executive Officer, GRAIL, LLC22.89M----61male04/14/2022
Dr. Phillip G. Febbo, M.D.Chief Medical Officer------55male04/14/2022
Ms. Aimee L. HoytChief People Officer------51female04/14/2022
Mr. Joydeep GoswamiInterim Chief Financial Officer, Chief Strategy and Corporate Development Officer------50male09/30/2022
Ms. Susan H. TousiChief Commercial Officer5.04M----52female04/14/2022
Mr. Alexander AravanisChief Technology Officer and Head of Research and Product Development5.05M----46male04/14/2022
Ms. Kathryne Gambrell ReevesChief Marketing Officer------53female04/14/2022
Ms. Carissa RollinsChief Information Officer------52female04/14/2022
Mr. Scott EricksenVice President and Chief Accounting Officer------50male09/30/2022
Mr. Charles E. DadswellGeneral Counsel and Secretary3.56M----63male04/14/2022
Mr. John W. ThompsonChairman of the Board482.70K----72male04/14/2022
Ms. Caroline D. DorsaIndependent Director455.37K----62female04/14/2022
Dr. Gary S. Guthart,PhDIndependent Director450.37K----56male04/14/2022
Mr. Philip W. SchillerIndependent Director435.37K----61male04/14/2022
Ms. Susan E. SiegelIndependent Director430.37K----61female04/14/2022
Dr. Robert S. Epstein, M.D.Independent Director445.37K----66male04/14/2022
Dr. Scott Gottlieb,M.D.Independent Director419.58K----49male04/14/2022
Dr. Frances H. Arnold, PhDIndependent Director440.37K----65female04/14/2022
Mr. Kevin Carl PegelsChief of Global Operations ------55male04/14/2022
Company Overview More
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
CEO: Mr. Francis A. DeSouza
Market: NASDAQ
Listing Date: 07/28/2000
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist